Soluble activin receptor type IIB treatment does not cause fat loss in mice with diet-induced obesity

Diabetes, Obesity and Metabolism

Volumn 14, Issue 3, 2012, Pages 279-282

  McPherron, A C ^a   Guo, T ^a   Wang, Q ^a   Portas, J ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Adipose tissue; Glucose metabolism; Insulin resistance; Metabolism; Skeletal muscle

Indexed keywords

ACTIVIN RECEPTOR 2; ACTIVIN RECEPTOR 2B; GLUCOSE; MYOSTATIN; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLUCOSE METABOLISM; LEAN BODY WEIGHT; LIPID DIET; MALE; MOUSE; MUSCLE MASS; NONHUMAN; OBESITY; PHARMACOLOGICAL BLOCKING; PROTEIN SYNTHESIS INHIBITION; SKELETAL MUSCLE; TREATMENT OUTCOME; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 84857034167     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2011.01520.x     Document Type: Article

References (12)

1. LeBrasseur NK, Walsh K, Arany Z. Metabolic benefits of resistance training and fast glycolytic skeletal muscle. Am J Physiol Endocrinol Metab 2010; 300: E3-E10.
2. Lee SJ. Extracellular regulation of myostatin: a molecular rheostat for muscle mass. Immunol Endocr Metab Agents Med Chem 2010; 10: 183-194.
3. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature 1997; 387: 83-90.
4. McPherron AC. Metabolic functions of myostatin and Gdf11. Immunol Endocr Metab Agents Med Chem 2010; 10: 217-231.
5. Guo T, Jou W, Chanturiya T, Portas J, Gavrilova O, McPherron AC. Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS One 2009; 4: e4937.
6. de Caestecker M. The transforming growth factor-β superfamily of receptors. Cytokine Growth Factor Rev 2004; 15: 1-11.
7. Lee SJ, Reed LA, Davies MV et al. Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc Natl Acad Sci U S A 2005; 102: 18117-18122.
8. Akpan I, Goncalves MD, Dhir R et al. The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity. Int J Obes (Lond) 2009; 33: 1265-1273.
9. Bernardo BL, Wachtmann TS, Cosgrove PG et al. Postnatal PPARdelta activation and myostatin inhibition exert distinct yet complimentary effects on the metabolic profile of obese insulin-resistant mice. PLoS One 2010; 5: e11307.
10. Izumiya Y, Hopkins T, Morris C et al. Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab 2008; 7: 159-172.
11. Zhao B, Wall RJ, Yang J. Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance. Biochem Biophys Res Commun 2005; 337: 248-255.
12. Hunter GR, Brock DW, Byrne NM, Chandler-Laney PC, Del Corral P, Gower BA. Exercise training prevents regain of visceral fat for 1 year following weight loss. Obesity (Silver Spring) 2009; 18: 690-695.